ArticleAdvances in therapy2017

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk.

Toshitsugu Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.